Trial Profile
First-line clofarabine vs cytarabine in older patients with AML
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2012
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms PaW
- 29 Dec 2012 New trial record
- 10 Dec 2012 Primary endpoint 'Complete-haematological-response-rate' has been met.
- 10 Dec 2012 Primary endpoint 'Remission-rate' has been met.